Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001141299-15-000012
Filing Date
2015-03-31
Accepted
2015-03-31 08:47:04
Documents
9
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A mcgc2014123110ka.htm 10-K/A 130958
2 CONSENT OF WARREN AVERETT LLC ex23212311410ka.htm EX-23.2 3609
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) ex31112311410ka.htm EX-31.1 12879
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) ex31212311410ka.htm EX-31.2 13029
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C ex32112311410ka.htm EX-32.1 7218
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C ex32212311410ka.htm EX-32.2 7227
7 CONSOLIDATED FINANCIAL STATEMENTS OF RADIOPHARMACY INVESTORS, LLC AND SUB ex991fsnotes-radiopharmacy.htm EX-99.1 301698
8 fsnotesradioimage1a.jpg GRAPHIC 945802
9 header3.jpg GRAPHIC 20833
  Complete submission text file 0001141299-15-000012.txt   1809634
Mailing Address 1001 19TH STREET NORTH 10TH FLOOR ARLINGTON VA 22209
Business Address 1001 19TH STREET NORTH 10TH FLOOR ARLINGTON VA 22209 7032477500
MCG CAPITAL CORP (Filer) CIK: 0001141299 (see all company filings)

EIN.: 541889518 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 814-00239 | Film No.: 15736763